«Brainomix recently took the decision to refocus on pharma partnerships and accelerate global market expansion. The funding will specifically be used to extrapolate new medical indications for AI-assisted biomarker imaging from the established stroke platform, initially for Interstitial Lung Disease (ILD) and cancer.»

«With ‘e-Stroke’, the Oxford-based specialist for biomarker imaging has developed a fully automated AI imaging solution for stroke assessment that serves two purposes: earlier diagnostics and better treatment decision-making.»

Article written by Anna Engberg. Photo by Brainomix



Mobi Health News